While only contributing to 6% of spear-phishing attacks, business email compromise has caused more than $12.5 billion in losses since 2013. Read More
Evidera had several representatives in attendance at NICE's Annual Conference to garner insight into their perspective on improving access to innovative treatments and what it means for our clients. Read More
In the 2019 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of current and evolving trends that are shaping the future of the industry. Read More
A successful product development strategy requires a comprehensive understanding of the market environment. Learn more… Read More
What does the word “feasibility” mean to you? It may seem like a simple question, but I have found that “feasibility” has many interpretations within the clinical research industry. When we work with Read More
When it comes to the conduct of pediatric clinical trials, there are number of things you need to consider in order to ensure the successful conduct of a study. While we can’t predict the outcome, pla Read More
Earlier this week, President Trump and the “Big 6” Republican leaders announced their long-awaited tax plan, setting the following goals for the proposal. Read More
Australia is regarded as one of the best places in the world to conduct clinical trials. Download the report for case studies with leading pharma companies to learn why. Read More
As we are passionate about bringing paradigm-shifting technologies to patients, we were excited by the opportunity to facilitate transatlantic collaborations between Boston’s biotech hub and the life Read More
In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More